(Q41589718)

4 October 2017

1 reference

title

Growth factors and myelin regeneration in multiple sclerosis (English)

1 reference

4 October 2017

0 references

H D Webster

1

1 reference

4 October 2017

1 April 1997

1 reference

Multiple Sclerosis Journal

4 October 2017

1 reference

4 October 2017

3

1 reference

4 October 2017

113-120

1 reference

4 October 2017

2

1 reference

The nerve growth factor 35 years later

4 October 2017

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Structure, Evolution, Expression and Regulation of Insulin-Like Growth Factors I and II

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Ciliary neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

The fibroblast growth factor family: structural and biological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Fibroblast growth factors in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Future prospects for the management of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Protein growth factors as potential therapies for central nervous system demyelinative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

The role of T cells in multiple sclerosis: implications for therapies targeting the T cell receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Mechanisms of damage and repair in multiple sclerosis--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Oligodendrocytes in the early course of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Oligodendrocyte injury is an early event in lesions of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Expression of insulin-like growth factor-binding protein 2 (IGF-BP 2) following transient hypoxia-ischemia in the infant rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factors in the response to cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Growth factors in CNS repair and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Neurotrophic factors in central nervous system trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-Like Growth Factor Binding Proteins: Structural and Molecular Relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factor-I (IGF-I) production by astroglial cells: regulation and importance for epidermal growth factor-induced cell replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin/insulin-like growth factor I and other epigenetic modulators of myelin basic protein expression in isolated oligodendrocyte progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Cell death and control of cell survival in the oligodendrocyte lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

In vivo analysis of glial cell phenotypes during a viral demyelinating disease in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Development and regeneration in the O-2A lineage: studies in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Mitogenic effect of axolemma-enriched fraction on cultured oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Neurite promoting activity of insulin, insulin-like growth factor I and nerve growth factor on spinal motoneurons is astrocyte dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Expression of insulin-like growth factor binding protein-4 (IGFBP-4) by rat neural cells--comparison to other IGFBPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Pattern of myelination and distribution of neuroglial cells along the developing optic system of the rat and rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

FGFs stimulate IGF binding protein synthesis without affecting IGF synthesis in rat astroblasts in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor-1 (IGF-1) receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Localization of insulin-like growth factor-1 mRNA in murine central nervous system during postnatal development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Transport of insulin-related peptides and glucose across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factors cross the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Effect of recombinant human insulin-like growth factor I and early total parenteral nutrition on immune depression following severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

The inflammatory lesion of T cell line transferred experimental autoimmune encephalomyelitis of the Lewis rat: distinct nature of parenchymal and perivascular infiltrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Insulin-like growth factor-1 stimulation of lymphopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Structure of platelet-derived growth factor: implications for functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Developmental distribution of platelet-derived growth factor in the mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Platelet-derived growth factor receptors of mouse central nervous system cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Glial cell diversification in the rat optic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

The macroglial cells of the rat optic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Neuron-oligodendroglial interactions during central nervous system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

21 January 2018

Oligodendrocyte origins

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Platelet-derived growth factor is mitogenic for O-2Aadult progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Developmental effects of basic fibroblast growth factor and platelet-derived growth factor on glial cells in a three-dimensional cell culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Oligodendrocyte maturation and myelin gene expression in PDGF-treated cultures from rat cerebral white matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Platelet-derived growth factor is a potent biologic response modifier of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

The heparin-binding (fibroblast) growth factor family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Characterization of cultured rat oligodendrocytes proliferating in a serum-free, chemically defined medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

FGF modulates the PDGF-driven pathway of oligodendrocyte development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Regulation of FGF receptors in the oligodendrocyte lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Angiogenic growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Altered acidic and basic fibroblast growth factor expression following spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Ciliary neurotrophic factor induces type-2 astrocyte differentiation in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Extracellular matrix-associated molecules collaborate with ciliary neurotrophic factor to induce type-2 astrocyte development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Does oligodendrocyte survival depend on axons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

Evidence that axons are mitogenic for oligodendrocytes isolated from adult animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300210

10.1177/135245859700300210

21 January 2018

Identifiers

DOI

0 references

PubMed ID

9291164

1 reference

PubMed ID

9291164